Loading insider details...
Beta
Latest Form 4 (Jun 17, 2026): Grant/Award of 31,000 ENGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | enGene Therapeutics Inc. (ENGN) | Grant/Award | 31,000 | n/a |
| May 21, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 41,800 | n/a |
| May 5, 2026 | FIRST FINANCIAL BANKSHARES INC (FFIN) | Grant/Award | 2,142 | n/a |
| Oct 30, 2025 | 89bio, Inc. (ETNB) | Disposition to Issuer | 20,000 | n/a |
| Jun 16, 2025 | enGene Holdings Inc. (ENGN) | Grant/Award | 22,500 | n/a |
| May 21, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,167 | n/a |
| Feb 5, 2025 | 89bio, Inc. (ETNB) | Grant/Award | 56,400 | n/a |
| Jun 18, 2024 | enGene Holdings Inc. (ENGN) | Grant/Award | 20,000 | n/a |
| Jun 7, 2024 | LUMOS PHARMA, INC. | Grant/Award | 3,328 | n/a |
| May 22, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 2,917 | n/a |